Introduction {#sec1}
============

Acid-sensing ion channels (ASICs), members of the degenerin/epithelial Na^+^ channel superfamily, are largely expressed in the mammalian nervous system ([@ref32]). ASIC1a is highly permeable to Ca^2+^ and localized in different brain regions with high synaptic density, including the hippocampus ([@ref3]; [@ref2]; [@ref37]; [@ref28]). ASIC1a is present at excitatory postsynaptic sites, being activated under normal and pathological conditions ([@ref33], [@ref36]; [@ref40]). In the last years, a growing body of evidence has shown that acidosis, through the activation of ASICs, contributes to synaptic plasticity, i.e., long-term potentiation and dendritic structural plasticity in hippocampal neurons, as well as learning and memory ([@ref34]; [@ref39]; [@ref40]; [@ref1]; [@ref30]; [@ref7]; [@ref17]; [@ref4]; [@ref21]).

Extracellular acidification occurs in the brain during many different physiological and pathological situations as elevated neural activity, increased metabolism, and neuronal injury. Several works suggested that the acidic pH of synaptic vesicles transiently influences local extracellular pH during neurotrasmitters release ([@ref18]; [@ref31]). According with this idea, it has been demonstrated that transient acidification of extracellular pH occurs in synaptic transmission in cultured hippocampal neurons ([@ref24]) and also in hippocampal slices ([@ref18]; [@ref33], [@ref36]). In light of these evidences, it has been proposed that ASICs provide a target for protons released in neurotransmission and thus play a role in the physiology of synaptic function ([@ref18]; [@ref31]; [@ref7]).

Several observations suggest that ASICs contribute to synaptic plasticity in different brain areas. Specifically ASICs facilitate activation of the N-methyl D-aspartate (NMDA) receptor during LTP induction, suggesting a functional interaction between these receptors in the regulation of hippocampal synaptic plasticity ([@ref34]; [@ref7]; [@ref4]; [@ref19]). Also, the coupling between NMDA receptor and ASIC has been shown to exacerbate acidity-mediated neuronal death occurring during ischemia ([@ref11], [@ref12]). More recently, our group has suggested a novel function of ASIC1a in the modulation of group I mGlu receptor-dependent synaptic plasticity and intrinsic excitability in the hippocampus ([@ref21]). To shed some light on the role of ASIC1a in another form of synaptic plasticity, here we performed an electrophysiological analysis to explore ASIC1a involvement in excitatory synaptic transmission and in NMDA receptor-dependent LTD in young and adult mice.

Materials and Methods {#sec2}
=====================

This study was carried out in accordance with the recommendations of international guidelines on the ethical use of animals from the European Communities Council Directive (2010/64/EU). The protocol was approved by the Ministero della Salute.

Slice Preparation {#sec3}
-----------------

C57BL6/J mice (13--40 days old) were deeply anesthetized with isoflurane and killed by decapitation.

The brain was rapidly removed from the skull and parasagittal hippocampal slices (250 μm) containing the dorsal hippocampus were cut with a vibratome (VT 1200S, Leica) in cold (0°C) artificial cerebrospinal fluid (aCSF) containing (in mM): NaCl (124); KCl (3); MgSO~4~ (1); CaCl~2~ (2); NaH~2~PO~4~ (1.25); NaHCO~3~ (26); glucose (10); saturated with 95% O~2~, 5% CO~2~ (pH 7.4), and left to recover for 1 h in ACSF at 33.5°C.

Electrophysiology {#sec4}
-----------------

Individual slices were placed in a recording chamber, on the stage of an upright microscope (Nikon, Japan) and submerged in a continuously flowing (3 ml/min) solution at 28°C (±0.2°C). Individual neurons were visualized through a 40× water-immersion objective (Nikon, Japan) connected to infrared video microscopy (Hamamatsu, Japan). Borosilicate glass electrodes (3--7 MΩ), pulled with a PP 83 Narishige puller, were filled with a solution containing the following (in mM): CsCl (135), KCl (10), CaCl~2~ (0.05), EGTA (0.1), Hepes (10), Na3-GTP (0.3), Mg-GTP (4.0), pH adjusted to 7.3 with CsOH or K-Gluconate (135); KCl (10); MgCl~2~ (2); CaCl~2~ (0.05); EGTA (0.1); HEPES (10); ATP (4); GTP (0.3), pH 7.3 with KOH as previously published ([@ref21]).

Whole-cell voltage clamp (at −70 mV holding potential) recordings were carried out with a MultiClamp 700B amplifier (Axon Instruments, Foster City, CA), filtered at 1 kHz and digitized (10 kHz).

The excitatory postsynaptic currents (EPSCs) were elicited at 0.033 Hz (EPSCs were elicited by stimulation every 30 s and each plot represents the mean of two consecutive EPSCs) with a glass pipette filled with ACSF, placed in CA1 *stratum radiatum* to stimulate Shaffer collateral fibers and in continuous presence of picrotoxin in bath solution as previously published ([@ref23]). For paired-pulse (PP) experiments, paired-pulse stimuli (50 ms inter-pulse interval) were elicited with stimulating electrode placed close to the recording neuron in the continuous presence of picrotoxin. Paired pulse ratio (PPR) was evaluated as ratio of second EPSC amplitude on first EPSC amplitude.

Low-frequency stimulation (LFS) was obtained by delivering 300 pulses (at 0.75 Hz) at −40 mV.

The ASIC1a inward current was elicited by a CSF buffered to pH 5.5 and pressure-applied (10 psi, 1 s) through a patch electrode connected to Pneumatic Pico-Injector. The puff electrode was positioned above the slice in close proximity to the recorded neuron, and the inward currents were elicited every 3 min.

Electrophysiological data are represented as mean values ± SEM. Statistical significance was evaluated by two-tailed Student's *t*-test on averaged mean values taken from the last 5 min of each experiment. Statistical significance was set at *p* \< 0.05 (indicated in the figures by \*).

Drugs {#sec5}
-----

Amiloride; 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX); D-2-amino-5-phosphonovaleric acid (D-AP5); isoflurane; picrotoxin; and N-methyl-d-aspartic acid (NMDA) were purchased from Sigma-Aldrich (Italy); and psalmotoxin-1 was purchased from Alomone Labs. All drugs were dissolved in water.

Results {#sec6}
=======

Acid-Sensing Ion Channel 1a-Mediated Currents in CA1 Pyramidal Neurons {#sec7}
----------------------------------------------------------------------

In order to assess whether ASIC1 contributes to basal excitatory transmission, we recorded excitatory postsynaptic currents (EPSCs) elicited by stimulation of the Schaffer collaterals fibers in the presence of PcTx-1, a polypeptide from the venom of spider toxin, that specifically inhibits homomeric ASIC1a currents ([@ref9]). Bath application of PcTx-1 (100 ng/ml) did not induce any significant change in EPSC amplitude (*p* \> 0.05, *n* = 12; [Figure 1A](#fig1){ref-type="fig"}). Also PPR, which is used to investigate the probability of neurotransmitter release, was unaffected following bath application of PcTx-1 (*p* \> 0.05, *n* = 8; [Figure 1B](#fig1){ref-type="fig"}), according to a postsynaptic localization of ASIC1a ([@ref10]). While protons activate an inward current in different brain areas ([@ref7]; [@ref13]; [@ref17]), we then investigated the impact of proton-activated current on the EPSC in CA1 pyramidal neurons. Application of the ionotropic glutamate receptor antagonists CNQX and D-AP5 strongly reduced EPSC amplitude to 10.6 ± 3% of control (*p* \< 0.05, *n* = 6; [Figure 1C](#fig1){ref-type="fig"}). In this condition, application of PcTx-1 (100 ng/ml) further reduced the current to 4 ± 2% of control (*p* \< 0.05, *n* = 6; [Figure 1C](#fig1){ref-type="fig"}). The amplitude of the ASIC1a-mediated current is very small and this explains why the effect of PcTx-1 is masked in baseline excitatory neurotransmission.

![ASIC1a contributes to excitatory synaptic transmission in hippocampal slices. **(A)** Normalized pooled data showing EPSCs in control condition and during PcTx-1 (100 ng/ml) bath application (mean ± SEM, *n* = 12, *p* \> 0.05). EPSC was elicited by monopolar electrode placed on Schaffer collateral fibers. On top, representative EPSC traces were taken at the time indicated by number. **(B)** Bar chart illustrates normalized PPR (50 ms inter-pulse interval) in control condition and during PcTx-1 (100 ng/ml) bath application (mean ± SEM, *n* = 8, *p* \> 0.05). On top, representative EPSC traces are shown. **(C)** Slices were perfused with picrotoxin (GABA~A~ receptor antagonist, grey), plus CNQX (30 μM; AMPA receptor antagonist) and D-AP5 (50 μM; NMDA receptors antagonist, red), and subsequently with 100 ng/ml PcTx-1 (pink). Panel shows one representative experiment, bar chart in the inset illustrates the amplitude of EPSC (% of control) in the different conditions (mean ± SEM, *n* = 6, \**p* \< 0.05).](fphar-10-00555-g001){#fig1}

Acid-Sensing Ion Channel 1a Contributes to Hippocampal N-Methyl D-Aspartate Receptor-Dependent Long-Term Depression in Young Mice {#sec8}
---------------------------------------------------------------------------------------------------------------------------------

We next investigated the involvement of ASIC1a in a specific form of NMDA receptor-dependent synaptic plasticity. It is known that low-frequency stimulation protocol induces a stable long-term depression of synaptic transmission ([@ref8]; [@ref26]). The induction of this form of LTD was completely inhibited by the NMDA receptor antagonist D-AP5 (50 μM) (data not shown).

We performed LTD experiments in young mice (P13-18) in the presence of PcTx-1 at different concentrations, applied 10 min before and during LFS protocol. PcTx-1 was able to reduce, in a dose-dependent manner, the magnitude of EPSC-LTD compared to control conditions (control: 32.2 ± 0.9% of baseline, *n* = 12; PcTx-1 30 ng/ml: 44.5 ± 0.9% of baseline, *n* = 10, *p* \< 0.001; PcTx-1,100 ng/ml: 59.1 ± 1.3% of baseline, *n* = 10, *p* \< 0.001, [Figure 2A](#fig2){ref-type="fig"}).

![ASIC1a modulates NMDA receptor-dependent LTD in young mice. **(A)** Normalized pooled data showing LTD in control condition (black) and in the presence of Pctx-1 applied before and during LFS (100 ng/ml, pink). Histogram represents the last 5 min of experiment in control (*n* = 12) condition or in the presence of PcTx-1 (30 ng/ml, mean ± SEM, *n* = 10, \*\*\**p* \< 0.001), (100 ng/ml, mean ± SEM, *n* = 10, \*\*\**p* \< 0.001). On top, representative traces are shown for each condition. **(B)** Normalized pooled data showing LTD in control condition (black) and in the presence of amiloride (100 μM, blue). Histogram represents the last 5 min of experiment in control condition (*n* = 12) or in presence of amiloride (*n* = 8) (mean ± SEM, \*\*\**p* \< 0.001). **(C)** Normalized pooled data showing LTD in control condition (black) and in the presence of PcTx-1 (100 ng/ml, pink) applied after LFS protocol. Histogram represents the last 5 min of experiment in control condition (*n* = 12) or in the presence of PcTx-1 (*n* = 6) (mean ± SEM, *p* \> 0.05).](fphar-10-00555-g002){#fig2}

To further confirm that ASIC1a is involved in this form of synaptic plasticity, we also performed experiments using the nonselective ASIC blocker amiloride (100 μM). Even under this condition, LTD magnitude was significantly reduced compared to control condition (62.3 ± 1.8% of baseline, *n* = 8, *p* \< 0.001, [Figure 2B](#fig2){ref-type="fig"}).

To distinguish whether ASIC1a plays a role in the induction or rather in the maintenance phase of LTD, we bath applied PcTx-1 10 min after the induction of LTD. Notably, in this condition PcTx-1 did not affect LTD magnitude (44.2 ± 0.8% of baseline, *n* = 6, *p* \> 0.05, [Figure 2C](#fig2){ref-type="fig"}).

Acid-Sensing Ion Channel 1a Contributes to Hippocampal N-Methyl D-Aspartate Receptor-Dependent Long-Term Depression in Adult Mice {#sec9}
---------------------------------------------------------------------------------------------------------------------------------

Long-term depression is strongly affected by the developmental stages of the brain ([@ref15]; [@ref16]). Thus, we extended our electrophysiological analysis also in slices obtained from adult mice (P30-40). Similar to young mice, in adult mice also, LTD magnitude was reduced when PcTx-1 (100 ng/ml) was applied (control: 55.1 ± 1.2% of baseline, *n* = 11, *p* \< 0.001, PcTx-1: 79.1 ± 1.5% of baseline, *n* = 9, *p* \< 0.001, [Figure 3A](#fig3){ref-type="fig"}). A comparable effect was also obtained in the presence of amiloride (100 μM) (81 ± 1% of baseline, *n* = 7, *p* \< 0.001 [Figure 3B](#fig3){ref-type="fig"}). Furthermore, we applied PcTx-1 after LTD induction and, as it occurred in young mice, no change was observed in LTD magnitude compared to control (49.7 ± 1.4% of baseline, *n* = 8, *p* \> 0.05, [Figure 3C](#fig3){ref-type="fig"}).

![ASIC1a modulates NMDA receptor-dependent LTD in adult mice. **(A)** Normalized pooled data showing LTD in control condition (black) and in the presence of Pctx-1 before and during LFS (100 ng/ml, pink). Histogram represents the last 5 min of experiment in control condition (*n* = 11) or in the presence of PcTx-1 (*n* = 9) (mean ± SEM, \*\*\**p* \< 0.001). On top, representative traces are shown for each condition. **(B)** Normalized pooled data showing LTD in control condition (black) and in the presence of amiloride (100 μM, blue). Histogram represents the last 5 min of experiment in control condition (*n* = 11) or in the presence of amiloride (*n* = 7) (mean ± SEM, \*\*\**p* \< 0.001). **(C)** Normalized pooled data showing LTD in control condition (black) and in the presence of PcTx-1 (100 ng/ml, pink) after LFS. Histogram represents the last 5 min of experiment in control condition (*n* = 11) or in the presence of PcTx-1 (*n* = 8) (mean ± SEM, *p* \> 0.05).](fphar-10-00555-g003){#fig3}

PcTx-1 Inhibits Chemical N-Methyl D-Aspartate Receptor-Dependent Long-Term Depression {#sec10}
-------------------------------------------------------------------------------------

To further confirm the role of ASIC1a in NMDA receptor-dependent LTD, we performed experiments using a chemical protocol based on the perfusion of NMDA on hippocampal slices obtained from young and adult mice ([@ref14]). Bath application of NMDA (20 μM, 3 min) on hippocampal slices from young animals induced a strong EPSC depression that was detectable 30 min after NMDA application (34.1 ± 5.1% of baseline, *n* = 9, [Figure 4A](#fig4){ref-type="fig"}). Application of PcTx-1 (100 ng/ml) 10 min before and during the perfusion of NMDA partially rescued LTD (72.9 ± 9% of baseline, *n* = 7, *p* \< 0.001, [Figure 4A](#fig4){ref-type="fig"}), suggesting that ASIC1a plays a modulatory role also in this form of LTD. Notably, bath application of PcTx-1 after NMDA-LTD induction did not restore the established depression of EPSC (39.4 ± 5% of baseline, *n* = 6, *p* \> 0.05, [Figure 4A](#fig4){ref-type="fig"}).

![PcTx-1 inhibits chemical NMDA-LTD. **(A)** Pooled data showing LTD induced by NMDA (20 μM) bath applied in slices obtained from young mice in control condition (*n* = 9) (black), in the presence of PcTx-1 (*n* = 7) (100 ng/ml, pink) applied before and during NMDA application, or applied after LTD induction (*n* = 6) (grey). Histogram represents the last 5 min of experiment in each condition (mean ± SEM, \*\*\**p* \< 0.001). On the top, representative traces are shown for each condition. **(B)** Pooled data showing LTD induced by NMDA (20 μM) bath applied in slices obtained from adult mice in control condition (*n* = 8) (black), in the presence of PcTx-1 (*n* = 7) (100 ng/ml, pink) applied before and during NMDA application, or applied after LTD induction (*n* = 5) (grey). Histogram represents the last 5 min of experiment in each condition (mean ± SEM, \*\*\**p* \< 0.001). On the top, representative traces are shown for each condition.](fphar-10-00555-g004){#fig4}

Similar results were obtained also in slices from adult mice. Indeed, NMDA perfusion induced a strong EPSC depression (56.6 ± 9% of baseline, *n* = 8, [Figure 4B](#fig4){ref-type="fig"}). Pharmacological blockade of ASIC1a before and during NMDA application rescued LTD (82.7 ± 9.5% of baseline, *n* = 7, [Figure 4B](#fig4){ref-type="fig"}). On the contrary, when PcTx-1 was applied after NMDA-LTD induction, LTD still persisted (52.4 ± 9.2% of baseline, *n* = 5, [Figure 4B](#fig4){ref-type="fig"}), suggesting that ASIC1a modulates NMDA receptor function *per se*, thereby affecting NMDA receptor-mediated LTD maintenance signaling.

PcTx-1 Converts Long-Term Depression of EPSC~NMDA~ to Potentiation {#sec11}
------------------------------------------------------------------

To explore the functional interplay between ASIC1a and NMDA receptors, we performed LTD experiments on the EPSC~NMDA~, pharmacologically isolated through bath application of picrotoxin and CNQX. Although here we refer to an EPSC~NMDA~ component, we cannot exclude, based on our previous results, that also ASIC1a may be contributing to this current.

Low-frequency stimulation produces a stable long-term depression of EPSC~NMDA~. Surprisingly, PcTx-1 applied before and during LFS was able to convert LTD to LTP (control: 55.4 ± 2.5% of baseline, *n* = 9; PcTx-1,100 ng/ml: 149.3 ± 3.2% of baseline, *n* = 7, *p* \< 0.001, [Figure 5A](#fig5){ref-type="fig"}), even though the mechanisms underlying this effect need to be explored.

![PcTx-1 converts LTD of EPSC~NMDA~ to LTP. **(A)** Normalized pooled data showing LTD of EPSC~NMDA~ in control condition (black) and in the presence of PcTx-1 before and during LFS (100 ng/ml, pink). Histogram represents the last 5 min of experiment in control condition (*n* = 9) or in the presence of PcTx-1 (*n* = 7) (mean ± SEM, \*\*\**p* \< 0.001). On top, representative traces are shown for each condition. **(B)** Histogram represents the amplitude of ASIC1a-mediated inward current (control condition), in the presence of NMDA up to 10 min later, and in the presence of PcTx-1 (*n* = 6, mean ± SEM, \*\*\**p* \< 0.001). On the left, representative traces are shown for each condition.](fphar-10-00555-g005){#fig5}

To investigate possible changes of ASIC-mediated currents following LTD induction, we performed experiments by delivering puff applications of ACSF at pH 5.5 which elicit inward currents mediated by ASIC1a. Puff applications were applied at a 3-min interval for 10 min before and 10 min after NMDA-LTD induction (NMDA 20 μM, 3 min). Interestingly, we observed an increase in the amplitude of ASIC inward current following NMDA-LTD induction (163 ± 13.2%, *n* = 6, *p* \< 0.001, [Figure 5B](#fig5){ref-type="fig"}), which was then completely abolished by PcTx-1 applied (control: 99.4 ± 2.5% vs. PcTx-1 2.8 ± 1.8%, *n* = 6 *p* \< 0.001; [Figure 5B](#fig5){ref-type="fig"}). Overall, these data confirm that a functional interplay between ASIC1a and NMDA receptors underlies specific forms of synaptic plasticity.

Discussion {#sec12}
==========

In the present study, we have demonstrated that ASIC1a contributes, although to a small extent, to basal excitatory postsynaptic currents in CA1 pyramidal neurons. Indeed in hippocampal slices, the proton-mediated current had a little effect on neurotransmission under basal condition comparable to what was already shown in the amygdala ([@ref7]). As previously demonstrated, neurotransmitters glutamate and H^+^ are released together during excitatory synaptic transmission bringing a rapid pH drop at synaptic cleft which activates ASICs ([@ref32],[@ref31]; [@ref6]; [@ref29]; [@ref39]).

Some studies have investigated the involvement of ASIC1a in synaptic plasticity and have shown that this channel was involved in the induction of LTP in different brain areas, such as the hippocampus and amygdala ([@ref34]; [@ref7]; [@ref4]). In addition, behavioral studies have shown that disrupting or over-expressing ASIC1a in mice might cause alteration in learning and conditioning ([@ref34], [@ref33], [@ref35]). Recently, we published the researches that demonstrated a role of ASIC1a in metabotropic glutamate (mGlu) receptor-dependent long-term depression (LTD) in the hippocampus ([@ref21]; [@ref22]). Our results suggest that ASIC1a plays a critical role in intrinsic excitability and mGlu receptor-dependent LTD in CA1 pyramidal neurons of early adult mice. Notably, ASIC1a controls AMPA-GluA1 subunit phosphorylation succeeding mGlu-LTD, suggesting that a functional crosstalk among ASIC1a and AMPA receptors underlies specific forms of synaptic plasticity ([@ref21]).

Here we extend these results by investigating the involvement of ASIC1a in a distinct form of synaptic plasticity. In particular, we studied the NMDA receptor-dependent form of LTD by the use of selective and nonselective ASIC1a blockers, psalmotoxin-1 and amiloride. We have shown that ASIC1a plays a role in NMDA-dependent long-term depression in young and adult hippocampus. Moreover, experiments performed on isolated EPSC~NMDA~ highlight that a functional crosstalk between the two receptors occurs and underlies specific forms of LTD. This interaction was also confirmed by monitoring, during NMDA-LTD experiments, the ASIC1a-mediated currents elicited by puff applications of acidic pH solution. Indeed, ASIC1a currents were increased following chemical LTD induction and were completely abated by PcTx-1 application. It is possible to hypothesize that in the absence of PcTx-1, LFS induces LTD of AMPA-mediated currents; whereas, in the presence of PcTx-1, LFS induces LTP of NMDA- or ASIC1a-mediated currents. Thus, when combining the LTD of AMPA-mediated currents and the potentiation of either NMDA-mediated or ASIC1a-mediated currents that occurs following LFS or NMDA application in the presence of PcTx-1, the end result is attenuation of LTD or unmasking of potentiation.

In any case, here we demonstrate that an interplay between ASICs and glutamate receptors (see also [@ref21]) underlies various forms of synaptic plasticity, even though the precise mechanisms mediating these interactions still remain unclear. [@ref12] have previously demonstrated interplay between ASIC1a and NMDA receptor function. In particular, they show that ASIC1a activity plays a key role in facilitating the opening of NMDA receptor channel, whereas inhibition of ASIC1a impaired NMDA receptor function at physiological pH ([@ref12]). Importantly, a recent paper has shown an increase of the NMDA receptor current following ASIC1a activation, which is mediated by the NR2 subunit ([@ref20]). Based on these results, here we suggest that ASICs' activation is involved in NMDA receptor-dependent LTD. It can be hypothesized that under synaptic activity, the opening of ASIC1a might contribute to depolarize the postsynaptic cell thus allowing Ca^2+^ to flow into the NMDA receptor within the dendritic spine and trigger LTD.

Overall, this work further supports a role for ASICs in regulating synaptic function and potentially cognitive processes. Future studies are required to elucidate how the interplay among ASICs and NMDA receptors might contribute to normal and pathological conditions. Interestingly, it is known that drugs that increase synaptic activity, such as NMDA receptor agonists or modulators, have been extensively explored as treatments to ameliorate memory function (for review see [@ref25]; [@ref5]). In this context, also ASICs might be considered as potential therapeutic targets in neurodegenerative disorders ([@ref38]; [@ref27]).
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aCSF

:   artificial cerebrospinal fluid

ASIC

:   acid sensing ion channel

EPSC

:   excitatory postsynaptic current

LFS

:   low-frequency stimulation

LTD

:   long-term depression

PcTx1

:   psalmotoxin-1.
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